Inflammation-Induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D

Cancer Discovery

Volumn 4, Issue 6, 2014, Pages 688-701

  Baumgart, Sandra ^a   Chen, Nai Ming ^a,b   Siveke, Jens T ^c   König, Alexander ^a,b,g   Zhang, Jin San ^g   Singh, Shiv K ⁱ   Wolf, Elmar ^e   Bartkuhn, Marek ^f   Esposito, Irene ^d   Heßmann, Elisabeth ^a,b   Reinecke, Johanna ^a,b   Nikorowitsch, Julius ^a   Brunner, Marius ^a   Singh, Garima ⁱ   Fernandez Zapico, Martin E ^g   Smyrk, Thomas ^g   Bamlet, William R ^g   Eilers, Martin ^e   Neesse, Albrecht ^a   Gress, Thomas M ^a   Billadeau, Daniel D ^g   Tuveson, David ^j   Urrutia, Raul ^h   Ellenrieder, Volker ^b   more..

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f JUSTUS LIEBIG UNIVERSITY   (Germany)

^g MAYO CLINIC   (United States)

^h MAYO GRADUATE SCHOOL   (United States)

ⁱ ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^j Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CERULETIDE; COLLAGENASE 3; CRE RECOMBINASE; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 4; CYTOKERATIN 19; EPIDERMAL GROWTH FACTOR RECEPTOR; HISTONE ACETYLTRANSFERASE; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; KI 67 ANTIGEN; PROTEIN P16; PROTEIN P48; STAT3 PROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG; WNT1 PROTEIN; WNT10A PROTEIN; KRAS2 PROTEIN, MOUSE; NFATC1 PROTEIN, MOUSE; PROTEIN P21; STAT3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; INFLAMMATION; MAJOR CLINICAL STUDY; METASTASIS; MOUSE; NONHUMAN; ONCOGENE K RAS; PANCREAS ADENOMA; PANCREAS CANCER; POLYMERASE CHAIN REACTION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TISSUE MICROARRAY; TRANSCRIPTION REGULATION; TUMOR GROWTH; ANIMAL; CHEMICALLY INDUCED; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PANCREAS TUMOR; PANCREATITIS; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CERULETIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE, TRANSGENIC; NFATC TRANSCRIPTION FACTORS; PANCREATIC NEOPLASMS; PANCREATITIS; PROTO-ONCOGENE PROTEINS P21(RAS); STAT3 TRANSCRIPTION FACTOR;

EID: 84904046340     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-13-0593     Document Type: Article

References (49)

1. Warshaw AL, Fernández-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992; 326: 455-65.
2. Hidalgo M. Pancreatic cancer. N Engl J Med 2010; 362: 1605-17.
3. Maitra A, Hruban RH. Pancreatic cancer. Annu Rev Pathol 2008; 3: 157-88.
4. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003; 4: 437-50.
5. Pylayeva-Gupta Y, Lee KE, Hajdu CH, Miller G, Bar-Sagi D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 2012; 21: 836-47.
6. Bayne LJ, Beatty GL, Jhala N, Clark CE, Rhim AD, Stanger BZ, et al. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 2012; 21: 822-35.
7. Vonderheide RH, Bayne LJ. Inflammatory networks and immune surveillance of pancreatic carcinoma. Curr Opin Immunol 2013; 25: 200-5.
8. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann R, Lankisch P, Andersen J, et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993; 328: 1-5.
9. Jura N, Archer H, Bar-Sagi D. Chronic pancreatitis, pancreatic adenocarcinoma and the black box in-between. Cell Res 2005; 15: 72-7.
10. Guerra C, Schuhmacher AJ, Cañamero M, Grippo PJ, Verdaguer L, Pérez-Gallego L, et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 2007; 11: 291-302.
11. Carrière C, Young AL, Gunn JR, Longnecker DS, Korc M. Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. Biochem Biophys Res Commun 2009; 382: 561-5.
12. Morris JP, Wang SC, Hebrok M. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer 2010; 10: 683-95.
13. Guerra C, Collado M, Navas C, Schuhmacher AJ, Hernández-Porras I, Cañamero M, et al. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 2011; 19: 728-39.
14. Collins MA, Bednar F, Zhang Y, Brisset J-C, Galbán S, Galbán CJ, et al. Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. J Clin Invest 2012; 122: 639-53.
15. Perez-Mancera PA, Guerra C, Barbacid M, Tuveson DA. What we have learned about pancreatic cancer from mouse models. Gastroenterology 2012; 142: 1079-92.
16. Northrop JP, Ho SN, Chen L, Thomas DJ, Timmerman LA, Nolan GP, et al. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 1994; 369: 497-502.
17. Lesina M, Kurkowski MU, Ludes K, Rose-John S, Treiber M, Klöppel G, et al. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 2011; 19: 456-69.
18. Buchholz M, Schatz A, Wagner M, Michl P, Linhart T, Adler G, et al. Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca 222/calcineurin signaling pathway. EMBO J 2006; 25: 3714-24.
19. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102: 15545-50.
20. Fukuda A, Wang SC, Morris JP, Folias AE, Liou A, Kim GE, et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 2011; 19: 441-55.
21. Machanick P, Bailey TL. MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics 2011; 27: 1696-7.
22. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 2010; 107: 21931-6.
23. Raney BJ, Cline MS, Rosenbloom KR, Dreszer TR, Learned K, Barber GP, et al. ENCODE whole-genome data in the UCSC genome browser. Nucleic Acids Res 2011; 39: 871-5.
24. McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, et al. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 2010; 28: 495-501.
25. Ardito CM, Grüner BM, Takeuchi KK, Lubeseder-Martellato C, Teichmann N, Mazur PK, et al. EGF receptor is required for KRAS-induced pancreatic tumorigenesis. Cancer Cell 2012; 22: 304-17.
26. Navas C, Hernández-Porras I, Schuhmacher AJ, Sibilia M, Guerra C, Barbacid M. EGF receptor signaling is essential for k-ras oncogenedriven pancreatic ductal adenocarcinoma. Cancer Cell 2012; 22: 318-30.
27. Al-Aynati MM, Radulovich N, Ho J, Tsao MS. Overexpression of G 1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis. Clin Cancer Res 2004; 10: 6598-605.
28. Radulovich N, Pham NA, Strumpf D, Leung L, Xie W, Jurisica I, et al. Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma. Mol Cancer 2010; 9: 24.
29. Marsman J, Horsfield JA. Long distance relationships: enhancerpromoter communication and dynamic gene transcription. Biochim Biophys Acta 2012; 1819: 1217-27.
30. Nolis IK, McKay DJ, Mantouvalou E, Lomvardas S, Merika M, Thanos D. Transcription factors mediate long-range enhancer-promoter interactions. Proc Natl Acad Sci U S A 2009; 106: 20222-7.
31. Iovanna JL, Marks DL, Fernandez-Zapico ME, Urrutia R. Mechanistic insights into self-reinforcing processes driving abnormal histogenesis during the development of pancreatic cancer. Am J Pathol 2013; 182: 1078-86.
32. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997; 15: 707-47.
33. Wu H, Peisley A, Graef IA, Crabtree GR. NFAT signaling and the invention of vertebrates. Trends Cell Biol 2007; 17: 251-60.
34. Baumgart S, Ellenrieder V, Fernandez-Zapico ME. Oncogenic transcription factors: cornerstones of inflammation-linked pancreatic carcinogenesis. Gut 2013; 62: 310-6.
35. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140: 883-99.
36. Corcoran RB, Contino G, Deshpande V, Tzatsos A, Conrad C, Benes CH, et al. STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. Cancer Res 2011; 71: 5020-9.
37. Li N, Grivennikov SI, Karin M. The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell 2011; 19: 429-31.
38. Tripathi P, Wang Y, Coussens M, Manda KR, Casey AM, Lin C, et al. Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms. Oncogene 2014; 33: 1840-9.
39. Kim K, Lee J, Kim JH, Jin HM, Zhou B, Lee SY, et al. Protein inhibitor of activated STAT 3 modulates osteoclastogenesis by downregulation of NFATc1 and osteoclast-associated receptor. J Immunol 2007; 178: 5588-94.
40. Kundumani-Sridharan V, Van Quyen D, Subramani J, Singh NK, Chin YE, Rao GN. Novel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of cyclin D1, with first phase influencing cell migration and second phase directing cell proliferation. J Biol Chem 2012; 287: 22463-82.
41. Bulger M, Groudine M. Functional and mechanistic diversity of distal transcription enhancers. Cell 2011; 144: 327-39.
42. Visel A, Rubin EM, Pennacchio LA. Genomic views of distant-acting enhancers. Nature 2009; 461: 199-205.
43. Amit R, Garcia HG, Phillips R, Fraser SE. Building enhancers from the ground up: a synthetic biology approach. Cell 2011; 146: 105-18.
44. Tang C-H, Chen C-F, Chen W-M, Fong Y-C. IL-6 increases MMP-13 expression and motility in human chondrosarcoma cells. J Biol Chem 2011; 286: 11056-66.
45. Nakhai H, Siveke JT, Mendoza-Torres L, Schmid RM. Conditional inactivation of Myc impairs development of the exocrine pancreas. Development 2008; 135: 3191-6.
46. Gu G, Wells JM, Dombkowski D, Preffer F, Aronow B, Melton DA. Global expression analysis of gene regulatory pathways during endocrine pancreatic development. Development 2004; 131: 165-79.
47. Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R, et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Gene Dev 2001; 15: 3243-8.
48. Aliprantis AO, Ueki Y, Sulyanto R, Park A, Sigrist KS, Sharma SM, et al. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Clin Invest 2008; 118: 3775-89.
49. Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008; 133: 1106-17.